| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2016PLoSO..1151702J |
| P356 | DOI | 10.1371/JOURNAL.PONE.0151702 |
| P932 | PMC publication ID | 4795798 |
| P698 | PubMed publication ID | 26986758 |
| P5875 | ResearchGate publication ID | 298797385 |
| P50 | author | Letitia Jones | Q59360206 |
| Joseph W Jackson | Q61163039 | ||
| Sanjay B Maggirwar | Q98512616 | ||
| P2860 | cites work | Circulating gp120 alters the blood-brain barrier permeability in HIV-1 gp120 transgenic mice | Q48482309 |
| Signaling mechanisms of HIV-1 Tat-induced alterations of claudin-5 expression in brain endothelial cells | Q48939388 | ||
| Assessment of permeability in barrier type of endothelium in brain using tracers: Evans blue, sodium fluorescein, and horseradish peroxidase | Q50273792 | ||
| Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice | Q24669724 | ||
| Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells | Q24682677 | ||
| Targeting platelet-derived soluble CD40 ligand: a new treatment strategy for HIV-associated neuroinflammation? | Q27010594 | ||
| Emerging roles for platelets as immune and inflammatory cells | Q27016553 | ||
| The CD40/CD154 receptor/ligand dyad | Q28202756 | ||
| HIV-1 gp120 induces cytokine expression, leukocyte adhesion, and transmigration across the blood-brain barrier: modulatory effects of STAT1 signaling | Q28304859 | ||
| Platelet Activation in Human Immunodeficiency Virus Type-1 Patients Is Not Altered with Cocaine Abuse | Q28548326 | ||
| Monocyte/macrophage trafficking in acquired immunodeficiency syndrome encephalitis: lessons from human and nonhuman primate studies | Q28751900 | ||
| Monocyte recruitment during infection and inflammation | Q29620067 | ||
| The achilles heel of the trojan horse model of HIV-1 trans-infection | Q33347130 | ||
| Presence of cross-reactive antibody between human immunodeficiency virus (HIV) and platelet glycoproteins in HIV-related immune thrombocytopenic purpura | Q33367982 | ||
| HIV-1 negatively affects the survival/maturation of cord blood CD34(+) hematopoietic progenitor cells differentiated towards megakaryocytic lineage by HIV-1 gp120/CD4 membrane interaction | Q33373320 | ||
| Thrombocytopenia in patients with dengue virus infection in the Brazilian Amazon | Q33377566 | ||
| Thrombocytopenia is strongly associated with simian AIDS in pigtail macaques | Q33384619 | ||
| Risk factors for thrombocytopenia in HIV-infected persons in the era of potent antiretroviral therapy | Q33386133 | ||
| Differences between the peripheral and the central nervous system in permeability to sodium fluorescein. | Q50943794 | ||
| CD4 and CD8 T cell immune activation during chronic HIV infection: roles of homeostasis, HIV, type I IFN, and IL-7. | Q51022678 | ||
| Spread of sodium fluorescein in normal brain tissue. A study of the mechanism of the blood-brain barrier. | Q51298982 | ||
| The HIV-1 transgenic rat as a model for HIV-1 infected individuals on HAART. | Q54454547 | ||
| CD40L stabilizes arterial thrombi by a β3 integrin–dependent mechanism | Q63354517 | ||
| Antigenic homology of HIV-1 GP41 and human platelet glycoprotein GPIIIa (integrin beta3). | Q64983189 | ||
| The blood-brain barrier | Q70478262 | ||
| HIV mediates a productive infection of the brain | Q73145576 | ||
| Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients | Q73351358 | ||
| Pulmonary complications of HIV infection: autopsy findings | Q74576203 | ||
| Platelet-derived CD40L: the switch-hitting player of cardiovascular disease | Q74627856 | ||
| Contribution of platelet activation to plasma IL-18 concentrations in HIV-infected AIDS patients | Q80217301 | ||
| Cooperation between platelet-derived CD154 and CD4+ T cells for enhanced germinal center formation | Q81757066 | ||
| Structural homology of HIV-1 GP41 and human platelet glycoprotein GPIIIa | Q82194976 | ||
| Increased levels of platelet microparticles in HIV-infected patients with good response to highly active antiretroviral therapy | Q84307947 | ||
| Platelets, inflammation and anti-inflammatory effects of antiplatelet drugs in ACS and CAD | Q85674366 | ||
| Platelets and neurovascular inflammation | Q86700895 | ||
| Enhanced activation of platelets with abnormal release of RANTES in human immunodeficiency virus type 1 infection | Q45758382 | ||
| Tight junction proteins as channel formers and barrier builders. | Q45963231 | ||
| Regulation of CD40L (CD154) and CD62P (p-selectin) surface expression upon GPIIb-IIIa blockade of platelets from stable coronary artery disease patients. | Q45987404 | ||
| Functional synergy between CD40 ligand and HIV-1 Tat contributes to inflammation: implications in HIV type 1 dementia. | Q48267759 | ||
| The effects of doxycycline administration on amino acid neurotransmitters in an animal model of neonatal hypoxia-ischemia | Q48443137 | ||
| HIV-1 gp120 proteins and gp160 peptides are toxic to brain endothelial cells and neurons: possible pathway for HIV entry into the brain and HIV-associated dementia | Q48447211 | ||
| Platelets and viruses: an ambivalent relationship. | Q33387549 | ||
| HIV-1 Tat-induced platelet activation and release of CD154 contribute to HIV-1-associated autoimmune thrombocytopenia | Q33393202 | ||
| The clinical significance of circulating B cells secreting anti-glycoprotein IIb/IIIa antibody and platelet glycoprotein IIb/IIIa in patients with primary immune thrombocytopenia | Q33403270 | ||
| Dengue induces platelet activation, mitochondrial dysfunction and cell death through mechanisms that involve DC-SIGN and caspases | Q33406043 | ||
| Platelet activation and platelet-monocyte aggregate formation contribute to decreased platelet count during acute simian immunodeficiency virus infection in pig-tailed macaques | Q33409074 | ||
| Platelets Contribute to BBB Disruption Induced by HIV and Alcohol | Q33427030 | ||
| Autoimmune Thrombocytopenic Purpura in Homosexual Men | Q33476017 | ||
| The SIV-infected rhesus monkey model for HIV-associated dementia and implications for neurological diseases | Q33594720 | ||
| Feline immunodeficiency virus (FIV) as a model for study of lentivirus infections: parallels with HIV. | Q33786404 | ||
| In vivo monocyte tropism of pathogenic feline immunodeficiency viruses | Q33817827 | ||
| A mouse model for study of systemic HIV-1 infection, antiviral immune responses, and neuroinvasiveness | Q33928648 | ||
| Holey barrier: claudins and the regulation of brain endothelial permeability | Q33965984 | ||
| Dyad of CD40/CD40 ligand fosters neuroinflammation at the blood-brain barrier and is regulated via JNK signaling: implications for HIV-1 encephalitis | Q34015684 | ||
| Platelets potentiate brain endothelial alterations induced by Plasmodium falciparum | Q34301265 | ||
| Predictive value of S-100β protein for prognosis in patients with moderate and severe traumatic brain injury: systematic review and meta-analysis | Q34337260 | ||
| Links between Progressive HIV-1 Infection of Humanized Mice and Viral Neuropathogenesis | Q34358241 | ||
| HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study | Q34370880 | ||
| Dysregulation of claudin-5 in HIV-induced interstitial pneumonitis and lung vascular injury. Protective role of peroxisome proliferator-activated receptor-γ. | Q34480264 | ||
| Excess soluble CD40L contributes to blood brain barrier permeability in vivo: implications for HIV-associated neurocognitive disorders | Q34517239 | ||
| The neuropathogenesis of feline immunodeficiency virus infection: barriers to overcome | Q34634294 | ||
| Loss of neuronal integrity during progressive HIV-1 infection of humanized mice | Q34690832 | ||
| Platelet activating factor contributes to vascular leak in acute dengue infection | Q35043739 | ||
| An infectious murine model for studying the systemic effects of opioids on early HIV pathogenesis in the gut | Q35108063 | ||
| Breaking down the barrier: the effects of HIV-1 on the blood-brain barrier. | Q35114694 | ||
| Dynamics of viral and proviral loads of feline immunodeficiency virus within the feline central nervous system during the acute phase following intravenous infection | Q35149650 | ||
| Monocytes mediate HIV neuropathogenesis: mechanisms that contribute to HIV associated neurocognitive disorders | Q35154529 | ||
| Retracted: Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in brain of HIV-1 transgenic rats | Q35218599 | ||
| Monocyte trafficking in acute and chronic inflammation | Q35230750 | ||
| Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients | Q35596004 | ||
| Neuropathologies in Transgenic Mice Expressing Human Immunodeficiency Virus Type 1 Tat Protein under the Regulation of the Astrocyte-Specific Glial Fibrillary Acidic Protein Promoter and Doxycycline | Q35749130 | ||
| Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis | Q35787684 | ||
| Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis | Q35788031 | ||
| Rho-mediated regulation of tight junctions during monocyte migration across the blood-brain barrier in HIV-1 encephalitis (HIVE) | Q35849738 | ||
| Detection of circulating platelet-monocyte complexes in persons infected with human immunodeficiency virus type-1. | Q35877953 | ||
| The packaging and maturation of the HIV-1 Pol proteins | Q36002732 | ||
| Viral disruption of the blood-brain barrier | Q36007851 | ||
| Mechanisms of the blood-brain barrier disruption in HIV-1 infection | Q36166123 | ||
| Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow | Q36342244 | ||
| Mice chronically infected with chimeric HIV resist peripheral and brain superinfection: a model of protective immunity to HIV. | Q36367066 | ||
| The emerging role of platelets in adaptive immunity | Q36379961 | ||
| Development of neurological disease is associated with increased immune activation in simian immunodeficiency virus-infected macaques | Q36414232 | ||
| Vaccine-induced protection from infection of mice by chimeric human immunodeficiency virus type 1, EcoHIV/NL4-3. | Q36416594 | ||
| The HIV-1 transgenic rat model of neuroHIV. | Q36578522 | ||
| CD44-mediated monocyte transmigration across Cryptococcus neoformans-infected brain microvascular endothelial cells is enhanced by HIV-1 gp41-I90 ectodomain | Q36599919 | ||
| The growing complexity of platelet aggregation | Q36740902 | ||
| Human immunodeficiency virus type 1 infection increases the in vivo capacity of peripheral monocytes to cross the blood-brain barrier into the brain and the in vivo sensitivity of the blood-brain barrier to disruption by lipopolysaccharide | Q36804543 | ||
| Current understanding of HIV-associated neurocognitive disorders pathogenesis | Q36932005 | ||
| Monocyte/macrophages and their role in HIV neuropathogenesis | Q36991666 | ||
| Humanized mouse models of HIV infection | Q37089865 | ||
| Early detection of simian immunodeficiency virus in the central nervous system following oral administration to rhesus macaques | Q37094265 | ||
| Transmission of chimeric HIV by mating in conventional mice: prevention by pre-exposure antiretroviral therapy and reduced susceptibility during estrus | Q37137806 | ||
| Nonhuman primate models of NeuroAIDS | Q37264017 | ||
| Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases | Q37307308 | ||
| Enhanced human immunodeficiency virus Type 1 expression and neuropathogenesis in knockout mice lacking Type I interferon responses | Q37410928 | ||
| Molecular mechanism and function of CD40/CD40L engagement in the immune system. | Q37474929 | ||
| Molecular mechanisms of neuroinvasion by monocytes-macrophages in HIV-1 infection | Q37726311 | ||
| Central nervous system complications in HIV disease: HIV-associated neurocognitive disorder | Q37966663 | ||
| Novel antiplatelet agents in acute coronary syndrome | Q38257119 | ||
| Platelet activity in the pathophysiology of inflammatory bowel diseases | Q38316931 | ||
| Role of platelets in allergic airway inflammation. | Q38519725 | ||
| Platelet factor 4 (CXCL4) facilitates human macrophage infection with HIV-1 and potentiates virus replication | Q39440973 | ||
| HIV-1-induced alterations of claudin-5 expression at the blood-brain barrier level | Q39515527 | ||
| Simian immunodeficiency virus encephalitis in rhesus macaques is associated with rapid disease progression. | Q39588377 | ||
| Longitudinal assessment of feline immunodeficiency virus kinetics in plasma by use of a quantitative competitive reverse transcriptase PCR | Q39869661 | ||
| CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. | Q40658295 | ||
| Platelet activation and aggregation promote lung inflammation and influenza virus pathogenesis. | Q41494592 | ||
| Blood-brain barrier disruption in simian immunodeficiency virus encephalitis | Q42495207 | ||
| Extracellular HIV-1 Tat up-regulates expression of matrix metalloproteinase-9 via a MAPK-NF-kappaB dependent pathway in human astrocytes | Q43131684 | ||
| Platelet function and HIV: a case-control study. | Q43153434 | ||
| HIV-1 gag proteins: diverse functions in the virus life cycle | Q43783202 | ||
| Clinical pharmacology of higher dose eptifibatide in percutaneous coronary intervention (the PRIDE study). | Q43796125 | ||
| HIV-1 Tat-mediated effects on focal adhesion assembly and permeability in brain microvascular endothelial cells | Q45140660 | ||
| Simian immunodeficiency virus disrupts extended lengths of the blood--brain barrier. | Q45424296 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| brain | Q1073 | ||
| neuronitis | Q17157137 | ||
| blood–brain barrier | Q221694 | ||
| P304 | page(s) | e0151702 | |
| P577 | publication date | 2016-01-01 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Modeling HIV-1 Induced Neuroinflammation in Mice: Role of Platelets in Mediating Blood-Brain Barrier Dysfunction | |
| P478 | volume | 11 |
| Q55255033 | EcoHIV infection of mice establishes latent viral reservoirs in T cells and active viral reservoirs in macrophages that are sufficient for induction of neurocognitive impairment. |
| Q38701621 | Frontline Science: c-Myc regulates P-selectin glycoprotein ligand-1 expression in monocytes during HIV-1 infection. |
| Q38768300 | HIV infection model of chronic obstructive pulmonary disease in mice |
| Q92537389 | High Neutrophil-to-Platelet Ratio Is Associated With Hemorrhagic Transformation in Patients With Acute Ischemic Stroke |
| Q48353365 | In vitro analysis of platelet function in acute aneurysmal subarachnoid haemorrhage |
| Q61446591 | Interaction of Treponema pallidum, the syphilis spirochete, with human platelets |
| Q64228002 | Intranasal insulin therapy reverses hippocampal dendritic injury and cognitive impairment in a model of HIV-associated neurocognitive disorders in EcoHIV-infected mice |
| Q40147390 | Nucleoside reverse transcriptase inhibitors (NRTIs) induce proinflammatory cytokines in the CNS via Wnt5a signaling |
| Q52623432 | Persistent EcoHIV infection induces nigral degeneration in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-intoxicated mice. |
| Q55004062 | Platelets in Immune Response to Virus and Immunopathology of Viral Infections. |
Search more.